| Identification |
| Name: | 2,3-Quinoxalinedione,1,4-dihydro-6-(1H-imidazol-1-yl)-7-nitro-, hydrochloride (1:1) |
| Synonyms: | 2,3-Quinoxalinedione,1,4-dihydro-6-(1H-imidazol-1-yl)-7-nitro-, monohydrochloride (9CI); YM 90K |
| CAS: | 154164-30-4 |
| Molecular Formula: | C11H7 N5 O4 . Cl H |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C11H7N5O4/c17-10-11(18)14-7-4-9(16(19)20)8(3-6(7)13-10)15-2-1-12-5-15/h1-5H,(H,13,17)(H,14,18) |
| Molecular Structure: |
 |
| Properties |
| Flash Point: | 290.4°C |
| Boiling Point: | 556.6°Cat760mmHg |
| Density: | g/cm3 |
| Refractive index: | 1.84 |
| Biological Activity: | Selective AMPA receptor antagonist (K i values are 84, 2200 and > 37000 nM for AMPA, kainate and NMDA receptors respectively). Neuroprotective; delays neuronal death in a global ischemia model and cerebral infarction in a focal ischemia model following postischemic administration. |
| Flash Point: | 290.4°C |
| Safety Data |
| |
 |
